vs

Side-by-side financial comparison of Global Net Lease, Inc. (GNL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Global Net Lease, Inc. is the larger business by last-quarter revenue ($117.0M vs $83.1M, roughly 1.4× PROCEPT BioRobotics Corp). Global Net Lease, Inc. runs the higher net margin — 41.2% vs -38.1%, a 79.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -15.1%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -11.1%).

Global Net Lease, Inc. is a publicly traded real estate investment trust that acquires, owns and manages a diversified portfolio of commercial real estate assets under long-term net lease contracts. Its property portfolio spans North America and Europe, covering industrial, office, retail and other key sectors, serving tenants across multiple industries to deliver consistent long-term returns for shareholders.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GNL vs PRCT — Head-to-Head

Bigger by revenue
GNL
GNL
1.4× larger
GNL
$117.0M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+35.3% gap
PRCT
20.2%
-15.1%
GNL
Higher net margin
GNL
GNL
79.3% more per $
GNL
41.2%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-11.1%
GNL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GNL
GNL
PRCT
PRCT
Revenue
$117.0M
$83.1M
Net Profit
$48.2M
$-31.6M
Gross Margin
64.9%
Operating Margin
94.7%
-4.1%
Net Margin
41.2%
-38.1%
Revenue YoY
-15.1%
20.2%
Net Profit YoY
838.7%
-27.9%
EPS (diluted)
$0.14
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GNL
GNL
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$117.0M
$76.4M
Q3 25
$121.0M
$83.3M
Q2 25
$124.9M
$79.2M
Q1 25
$132.4M
$69.2M
Q4 24
$137.8M
$68.2M
Q3 24
$138.7M
$58.4M
Q2 24
$145.5M
$53.4M
Net Profit
GNL
GNL
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$48.2M
$-29.8M
Q3 25
$-60.1M
$-21.4M
Q2 25
$-24.1M
$-19.6M
Q1 25
$-189.4M
$-24.7M
Q4 24
$-6.5M
$-18.9M
Q3 24
$-65.6M
$-21.0M
Q2 24
$-35.7M
$-25.6M
Gross Margin
GNL
GNL
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
GNL
GNL
PRCT
PRCT
Q1 26
-4.1%
Q4 25
94.7%
-40.6%
Q3 25
-11.7%
-27.8%
Q2 25
33.9%
-28.0%
Q1 25
-21.1%
-39.7%
Q4 24
40.8%
-28.9%
Q3 24
9.3%
-38.4%
Q2 24
42.6%
-50.3%
Net Margin
GNL
GNL
PRCT
PRCT
Q1 26
-38.1%
Q4 25
41.2%
-39.1%
Q3 25
-49.7%
-25.7%
Q2 25
-19.3%
-24.7%
Q1 25
-143.0%
-35.8%
Q4 24
-4.7%
-27.6%
Q3 24
-47.3%
-35.9%
Q2 24
-24.5%
-48.0%
EPS (diluted)
GNL
GNL
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.14
$-0.54
Q3 25
$-0.32
$-0.38
Q2 25
$-0.16
$-0.35
Q1 25
$-0.87
$-0.45
Q4 24
$-0.08
$-0.34
Q3 24
$-0.33
$-0.40
Q2 24
$-0.20
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GNL
GNL
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$180.1M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$1.7B
$347.7M
Total Assets
$4.3B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GNL
GNL
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$180.1M
$286.5M
Q3 25
$165.1M
$294.3M
Q2 25
$144.8M
$302.7M
Q1 25
$147.0M
$316.2M
Q4 24
$159.7M
$333.7M
Q3 24
$127.2M
$196.8M
Q2 24
$122.2M
$214.1M
Total Debt
GNL
GNL
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
GNL
GNL
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$1.7B
$365.9M
Q3 25
$1.7B
$380.3M
Q2 25
$1.8B
$385.8M
Q1 25
$1.9B
$389.2M
Q4 24
$2.2B
$402.2M
Q3 24
$2.3B
$241.2M
Q2 24
$2.4B
$251.8M
Total Assets
GNL
GNL
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$4.3B
$508.1M
Q3 25
$4.8B
$511.5M
Q2 25
$5.0B
$513.1M
Q1 25
$5.8B
$519.4M
Q4 24
$7.0B
$534.0M
Q3 24
$7.3B
$374.1M
Q2 24
$7.6B
$374.4M
Debt / Equity
GNL
GNL
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GNL
GNL
PRCT
PRCT
Operating Cash FlowLast quarter
$222.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.62×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GNL
GNL
PRCT
PRCT
Q1 26
Q4 25
$222.8M
$-10.3M
Q3 25
$56.0M
$-6.6M
Q2 25
$52.0M
$-15.0M
Q1 25
$59.2M
$-17.0M
Q4 24
$299.5M
$-32.4M
Q3 24
$62.1M
$-18.8M
Q2 24
$70.4M
$-15.7M
Free Cash Flow
GNL
GNL
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
GNL
GNL
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
GNL
GNL
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
GNL
GNL
PRCT
PRCT
Q1 26
Q4 25
4.62×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GNL
GNL

Industrial And Distribution Segment$56.0M48%
Office Segment$30.8M26%
Single Tenant Retail Segment$30.2M26%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons